Clinical Trial Update: A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 safety and efficacy trial for diabetic neuropathic pain sponsored by AbbVie.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathic Pain

Drugs mentioned

• Not disclosed

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Diabetic Neuropathic Pain | Phase 2 | Status: COMPLETED